Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
U.S.C./Norris Comprehensive Cancer Center
2586
mi
from 02139
Los Angeles, CA
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
U.S.C./Norris Comprehensive Cancer Center
2586
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Siteman Cancer Center - West County
1045
mi
from 02139
Creve Coeur, MO
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Siteman Cancer Center - West County
1045
mi
from 02139
Creve Coeur, MO
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
184
mi
from 02139
New York, NY
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
184
mi
from 02139
New York, NY
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
184
mi
from 02139
New York, NY
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
184
mi
from 02139
New York, NY
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Seattle Cancer Care Alliance
2482
mi
from 02139
Seattle, WA
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Seattle Cancer Care Alliance
2482
mi
from 02139
Seattle, WA
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Indiana Blood and Marrow Transplantation - Administrative Offices
801
mi
from 02139
Indianapolis, IN
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Indiana Blood and Marrow Transplantation - Administrative Offices
801
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Indiana Blood and Marrow Transplantation Clinic
801
mi
from 02139
Indianapolis, IN
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Indiana Blood and Marrow Transplantation Clinic
801
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
1036
mi
from 02139
Saint Louis, MO
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
1036
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
1036
mi
from 02139
Saint Louis, MO
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
1036
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Siteman Cancer Center-South County
1045
mi
from 02139
Saint Louis, MO
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Siteman Cancer Center-South County
1045
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Keck Hospital of USC
2588
mi
from 02139
Los Angeles, CA
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Keck Hospital of USC
2588
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Lac & Usc Medical Center
2586
mi
from 02139
Los Angeles, CA
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Lac & Usc Medical Center
2586
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Sylvester at Deerfield Beach
1222
mi
from 02139
Deerfield Beach, FL
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Sylvester at Deerfield Beach
1222
mi
from 02139
Deerfield Beach, FL
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
University of Miami Hospital and Clinics
1256
mi
from 02139
Miami, FL
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
University of Miami Hospital and Clinics
1256
mi
from 02139
Miami, FL
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Medizinische Universitaet Innsbruck
3864
mi
from 02139
Innsbruck,
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Medizinische Universitaet Innsbruck
3864
mi
from 02139
Innsbruck,
Click here to add this to my saved trials
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center
356
mi
from 02139
Baltimore, MD
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
A PHASE 4 SAFETY AND EFFICACY STUDY OF BOSUTINIB (BOSULIF (REGISTERED)) IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA PREVIOUSLY TREATED WITH ONE OR MORE TYROSINE KINASE INHIBITORS
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center
356
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
A Phase 2, Open-Label Study to Evaluate the Safety, Microbiology and Pharmacokinetics of C16G2 Administered in Single or Multiple Oral Gel Doses to Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
Plaza West II Dental Group
2109
mi
from 02139
Kalispell, MT
Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
A Phase 2, Open-Label Study to Evaluate the Safety, Microbiology and Pharmacokinetics of C16G2 Administered in Single or Multiple Oral Gel Doses to Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Plaza West II Dental Group
2109
mi
from 02139
Kalispell, MT
Click here to add this to my saved trials
Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
A Phase 2, Open-Label Study to Evaluate the Safety, Microbiology and Pharmacokinetics of C16G2 Administered in Single or Multiple Oral Gel Doses to Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
Jean Brown Research
2091
mi
from 02139
Salt Lake City, UT
Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
A Phase 2, Open-Label Study to Evaluate the Safety, Microbiology and Pharmacokinetics of C16G2 Administered in Single or Multiple Oral Gel Doses to Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Jean Brown Research
2091
mi
from 02139
Salt Lake City, UT
Click here to add this to my saved trials
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated:  12/31/1969
William Beaumont Hospital
616
mi
from 02139
Royal Oak, MI
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
616
mi
from 02139
Royal Oak, MI
Click here to add this to my saved trials
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
940
mi
from 02139
Nashville, TN
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
940
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
929
mi
from 02139
Atlanta, GA
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
929
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated:  12/31/1969
University of Miami School of Medicine
1260
mi
from 02139
Miami, FL
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated: 12/31/1969
University of Miami School of Medicine
1260
mi
from 02139
Miami, FL
Click here to add this to my saved trials
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated:  12/31/1969
McKay Urology
719
mi
from 02139
Charlotte, NC
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status: Enrolling
Updated: 12/31/1969
McKay Urology
719
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
Impact of Vitamin D on 25-hydroxyvitamin D Levels and Physical Function
The Impact of Supplemental Vitamin D on Serum 25-hydroxyvitamin D Levels and Short Term Indicators of Physical Function
Status: Enrolling
Updated:  12/31/1969
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
2
mi
from 02139
Boston, MA
Impact of Vitamin D on 25-hydroxyvitamin D Levels and Physical Function
The Impact of Supplemental Vitamin D on Serum 25-hydroxyvitamin D Levels and Short Term Indicators of Physical Function
Status: Enrolling
Updated: 12/31/1969
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
A Prospective Cross-Sectional and Longitudinal Study With Additional Retrospective Chart Review to Evaluate Clinical and Biochemical Characteristics and Disease Progression in Patients With Mucopolysaccharidosis Type IIIB
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1117
mi
from 02139
Minneapolis, MN
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
A Prospective Cross-Sectional and Longitudinal Study With Additional Retrospective Chart Review to Evaluate Clinical and Biochemical Characteristics and Disease Progression in Patients With Mucopolysaccharidosis Type IIIB
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1117
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
A Prospective Cross-Sectional and Longitudinal Study With Additional Retrospective Chart Review to Evaluate Clinical and Biochemical Characteristics and Disease Progression in Patients With Mucopolysaccharidosis Type IIIB
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
479
mi
from 02139
Pittsburgh, PA
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
A Prospective Cross-Sectional and Longitudinal Study With Additional Retrospective Chart Review to Evaluate Clinical and Biochemical Characteristics and Disease Progression in Patients With Mucopolysaccharidosis Type IIIB
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
479
mi
from 02139
Pittsburgh, PA
Click here to add this to my saved trials
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
A Prospective Cross-Sectional and Longitudinal Study With Additional Retrospective Chart Review to Evaluate Clinical and Biochemical Characteristics and Disease Progression in Patients With Mucopolysaccharidosis Type IIIB
Status: Enrolling
Updated:  12/31/1969
Investigational Site Number 4104
5159
mi
from 02139
Porto Alegre,
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
A Prospective Cross-Sectional and Longitudinal Study With Additional Retrospective Chart Review to Evaluate Clinical and Biochemical Characteristics and Disease Progression in Patients With Mucopolysaccharidosis Type IIIB
Status: Enrolling
Updated: 12/31/1969
Investigational Site Number 4104
5159
mi
from 02139
Porto Alegre,
Click here to add this to my saved trials
A Comparison of Three Psychoeducational Group Interventions for Veterans With Tinnitus
A Comparison of CBT and CET Interventions for Veterans With Tinnitus
Status: Enrolling
Updated:  12/31/1969
VA Portland Health Care System, Portland, OR
2531
mi
from 02139
Portland, OR
A Comparison of Three Psychoeducational Group Interventions for Veterans With Tinnitus
A Comparison of CBT and CET Interventions for Veterans With Tinnitus
Status: Enrolling
Updated: 12/31/1969
VA Portland Health Care System, Portland, OR
2531
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Intravesicular Onabotulinumtoxin A in Interstitial Cystitis
The Impact of Injection Location on the Efficacy of Intravesicular Onabotulinumtoxin A in Interstitial Cystitis--Phase 4
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
654
mi
from 02139
Winston-Salem, NC
Intravesicular Onabotulinumtoxin A in Interstitial Cystitis
The Impact of Injection Location on the Efficacy of Intravesicular Onabotulinumtoxin A in Interstitial Cystitis--Phase 4
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
654
mi
from 02139
Winston-Salem, NC
Click here to add this to my saved trials
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
390
mi
from 02139
Bethesda, MD
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
390
mi
from 02139
Bethesda, MD
Click here to add this to my saved trials
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Status: Enrolling
Updated:  12/31/1969
National Human Genome Research Institute (NHGRI)
390
mi
from 02139
Bethesda, MD
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Status: Enrolling
Updated: 12/31/1969
National Human Genome Research Institute (NHGRI)
390
mi
from 02139
Bethesda, MD
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1117
mi
from 02139
Minneapolis, MN
Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1117
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
479
mi
from 02139
Pittsburgh, PA
Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
479
mi
from 02139
Pittsburgh, PA
Click here to add this to my saved trials
Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
Status: Enrolling
Updated:  12/31/1969
Research Site
3645
mi
from 02139
Barcelona,
Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
Status: Enrolling
Updated: 12/31/1969
Research Site
3645
mi
from 02139
Barcelona,
Click here to add this to my saved trials
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
1052
mi
from 02139
Birmingham, AL
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
1052
mi
from 02139
Birmingham, AL
Click here to add this to my saved trials
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated:  12/31/1969
University of Florida
1078
mi
from 02139
Gainesville, FL
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated: 12/31/1969
University of Florida
1078
mi
from 02139
Gainesville, FL
Click here to add this to my saved trials
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated:  12/31/1969
HealthPartners Institute for Education and Research
1124
mi
from 02139
Minneapolis, MN
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated: 12/31/1969
HealthPartners Institute for Education and Research
1124
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated:  12/31/1969
University of Rochester
335
mi
from 02139
Rochester, NY
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated: 12/31/1969
University of Rochester
335
mi
from 02139
Rochester, NY
Click here to add this to my saved trials
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Center for Health Research
2530
mi
from 02139
Portland, OR
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Center for Health Research
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
1762
mi
from 02139
San Antonio, TX
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
1762
mi
from 02139
San Antonio, TX
Click here to add this to my saved trials
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Covance Clinical Research Unit, Inc.
1062
mi
from 02139
Daytona Beach, FL
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Unit, Inc.
1062
mi
from 02139
Daytona Beach, FL
Click here to add this to my saved trials
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Covance Clinical Research Unit Inc.
918
mi
from 02139
Evansville, IN
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Unit Inc.
918
mi
from 02139
Evansville, IN
Click here to add this to my saved trials
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Covance Clinical Research Unit, Inc.
1549
mi
from 02139
Dallas, TX
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Unit, Inc.
1549
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Covance Clinical Research Unit
921
mi
from 02139
Madison, WI
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Unit
921
mi
from 02139
Madison, WI
Click here to add this to my saved trials
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated:  12/31/1969
Sacramento ENT
2621
mi
from 02139
Sacramento, CA
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated: 12/31/1969
Sacramento ENT
2621
mi
from 02139
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated:  12/31/1969
Colorado ENT & Allergy
1773
mi
from 02139
Colorado Springs, CO
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated: 12/31/1969
Colorado ENT & Allergy
1773
mi
from 02139
Colorado Springs, CO
Click here to add this to my saved trials
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated:  12/31/1969
ENT Associates of South Florida
1213
mi
from 02139
Boca Raton, FL
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated: 12/31/1969
ENT Associates of South Florida
1213
mi
from 02139
Boca Raton, FL
Click here to add this to my saved trials
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated:  12/31/1969
QPS MRA (Miami Research Associates)
1264
mi
from 02139
Miami, FL
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated: 12/31/1969
QPS MRA (Miami Research Associates)
1264
mi
from 02139
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated:  12/31/1969
University of South Florida
1174
mi
from 02139
Tampa, FL
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated: 12/31/1969
University of South Florida
1174
mi
from 02139
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated:  12/31/1969
University of Louisville
821
mi
from 02139
Louisville, KY
Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]
Status: Enrolling
Updated: 12/31/1969
University of Louisville
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials